v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity
(unaudited) - USD ($)
Total
Private Placement
Series B Preferred Warrants
Commitment Warrant
Pre-Funded Warrants
Common Stock
Common Stock
Debt Exchange Warrants
Common Stock
Series B Preferred Warrants
Common Stock
Commitment Warrant
Common Stock
2024 Prepaid Warrants
Preferred Stock
Preferred Stock - Series A
Preferred Stock
Preferred Stock - Series B
Preferred Stock
Preferred Stock - Series B
Private Placement
Additional Paid-in Capital
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Series B Preferred Warrants
Additional Paid-in Capital
Commitment Warrant
Accumulated Deficit
Common stock, beginning balance (in shares) at Dec. 31, 2024           13,184                        
Beginning balance at Dec. 31, 2024 $ 791,767         $ 1         $ 49 $ 0   $ 74,925,735       $ (74,134,018)
Beginning balance (in shares) at Dec. 31, 2024                     494,840 0            
Private placement of series B preferred stock (and warrants) (in shares)                         167,981          
Private Placement of Series B Preferred Stock (and warrants)   $ 1,679,810                     $ 17   $ 1,679,793      
Exercise of ELOC commitment warrant (in shares)                 167                  
Exercise of ELOC Commitment Warrant       $ 67                         $ 67  
Exercise of warrants (in shares)           825       3,126                
Exercise of warrants 232,427                         232,427        
Effect of reverse split and fractional shares (in shares)           1                        
Net Income / (Loss) (3,033,047)                                  
Common stock, ending balance (in shares) at Mar. 31, 2025           17,303                        
Ending balance at Mar. 31, 2025 (328,976)         $ 1         $ 49 $ 17   76,838,022       (77,167,065)
Ending balance (in shares) at Mar. 31, 2025                     494,840 167,981            
Common stock, beginning balance (in shares) at Dec. 31, 2024           13,184                        
Beginning balance at Dec. 31, 2024 $ 791,767         $ 1         $ 49 $ 0   74,925,735       (74,134,018)
Beginning balance (in shares) at Dec. 31, 2024                     494,840 0            
Exercise of ELOC commitment warrant (in shares)               400,505                    
Common stock, ending balance (in shares) at Dec. 31, 2025 482,554         482,554                        
Ending balance at Dec. 31, 2025 $ 98,216,130         $ 48         $ 21     310,065,394       (211,849,333)
Ending balance (in shares) at Dec. 31, 2025                     210,700              
Exercise of PIPE prepaid warrants for common stock (in shares)         4,185                          
Exercise of PIPE advisor warrants for common stock (in shares)           1,061                        
Exercise of ELOC commitment warrant (in shares)               24,011                    
Exercise of warrants (in shares)             1,341 17,424                    
Exercise of warrants     $ 0         $ 2               $ (2)    
RSUs vested (in shares)           7,604                        
RSUs Vested 0         $ 1               (1)        
RSU Share-based Compensation 942,909                         $ 942,909        
Effect of reverse split and fractional shares (in shares)           2                        
Net Income / (Loss) $ (66,744,989)                                 (66,744,989)
Common stock, ending balance (in shares) at Mar. 31, 2026 514,171                                  
Ending balance at Mar. 31, 2026 $ 32,414,050                   $ 21             $ (278,594,322)